Edward Hogan to Sphingolipids
This is a "connection" page, showing publications Edward Hogan has written about Sphingolipids.
Connection Strength
1.513
-
Distinctive sphingolipid patterns in chronic multiple sclerosis lesions. J Lipid Res. 2020 11; 61(11):1464-1479.
Score: 0.553
-
Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration. J Neurol Sci. 2018 02 15; 385:198-214.
Score: 0.461
-
Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. Neurochem Res. 2012 Jun; 37(6):1154-69.
Score: 0.310
-
Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids. J Lipid Res. 2001 Feb; 42(2):301-8.
Score: 0.143
-
Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line. J Lipid Res. 2016 11; 57(11):2028-2039.
Score: 0.026
-
Effect of lead intoxication on the postnatal growth of the rat nervous system. Environ Health Perspect. 1974 May; 7:187-99.
Score: 0.006
-
Fatty acid composition of cerebrosides, sulphatides and ceramides in murine leucodystrophy: the quaking mutant. J Neurochem. 1972 Feb; 19(2):307-12.
Score: 0.005
-
Fatty acid composition of cerebrosides, sulphatides and ceramides in murine sudanophilic leucodystrophy: the Jimpy mutant. J Neurochem. 1971 Sep; 18(9):1639-45.
Score: 0.005
-
Cerebral lipid composition during myelination in murine genetic leukodystrophies. Neurology. 1970 Apr; 20(4):416.
Score: 0.004